Provenge vaccine boosts survival for men with prostate cancer
News about Provenge vaccine … getting closer:
Provenge prostate cancer vaccine linked to longer survival for asymptomatic hormone refractory stage — UCSF study. June 28, 2006.
Dendreon Announces Publication of Pivotal Phase 3 Study Highlighting Survival Benefit and Safety Profile of PROVENGE in Men with Advanced Prostate Cancer June 29, 2006
Dendreon Announces FDA Grants Fast Track Status for Provenge